Published in Cancer Weekly, December 16th, 1996
The results of the trials were presented at the 82nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), held in Chicago, Illinois, December 1-5, 1996. The study showed sestamibi breast imaging may be a useful adjunctive tool for diagnosing breast cancer in difficult-to-image patients and patients with inconclusive mammograms.
"Sestamibi breast imaging shows real promise for aiding in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.